BLUEBIRD BIO, INC. On January 3, 2023, bluebird bio, Inc. announced that Joseph Vittiglio, JD, has been appointed Chief Business and Legal Officer of the Company. Mr. Vittiglio brings more than 20 years of experience in the biopharmaceutical industry, with expertise in licensing, collaborations and mergers and acquisitions, financial transactions, U.S. Food and Drug Administration regulations, compliance, manufacturing, and quality operations for organizations at all stages of development. Mr. Vittiglio joined the Company from Finch Therapeutics Group, Inc, where he previously served as Chief Business and Legal Officer.
Prior to joining Finch, he was the General Counsel and Chief Business Officer for AMAG Pharmaceuticals, Inc., where he led the company's legal and business development initiatives, including oversight of the successful sale of the company to private equity investors, multiple out-licensing and partnership collaborations, and multiple therapeutic product launches.
